See more : Hulamin Limited (HLM.JO) Income Statement Analysis – Financial Results
Complete financial analysis of U.S. Physical Therapy, Inc. (USPH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of U.S. Physical Therapy, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Thimble Point Acquisition Corp. (THMAW) Income Statement Analysis – Financial Results
- Family Room Entertainment Corporation (FMYR) Income Statement Analysis – Financial Results
- Land Securities Group plc (LAND.L) Income Statement Analysis – Financial Results
- SCVX Corp. (SCVX-UN) Income Statement Analysis – Financial Results
- Pernod Ricard SA (PRNDY) Income Statement Analysis – Financial Results
U.S. Physical Therapy, Inc. (USPH)
About U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 604.80M | 553.14M | 495.02M | 422.97M | 481.97M | 453.91M | 414.05M | 356.55M | 331.30M | 305.07M | 264.06M | 252.09M | 237.01M | 211.23M | 201.41M | 187.69M | 151.69M | 135.19M | 132.12M | 118.31M | 105.57M | 94.74M | 80.95M | 63.22M | 49.94M | 44.00M | 38.80M | 32.20M | 24.90M | 17.20M | 8.40M | 2.40M | 600.00K |
| Cost of Revenue | 492.82M | 441.12M | 377.84M | 328.52M | 369.50M | 352.25M | 323.43M | 274.53M | 252.94M | 228.91M | 199.36M | 189.50M | 172.51M | 151.82M | 146.24M | 140.08M | 114.33M | 99.35M | 96.21M | 85.28M | 74.60M | 64.53M | 54.88M | 42.90M | 34.09M | 30.80M | 27.30M | 22.10M | 17.40M | 13.20M | 6.20M | 1.70M | 500.00K |
| Gross Profit | 111.99M | 112.02M | 117.18M | 94.45M | 112.47M | 101.66M | 90.62M | 82.01M | 78.36M | 76.17M | 64.70M | 62.59M | 64.49M | 59.42M | 55.17M | 47.60M | 37.36M | 35.84M | 35.91M | 33.03M | 30.96M | 30.21M | 26.07M | 20.32M | 15.84M | 13.20M | 11.50M | 10.10M | 7.50M | 4.00M | 2.20M | 700.00K | 100.00K |
| Gross Profit Ratio | 18.52% | 20.25% | 23.67% | 22.33% | 23.34% | 22.40% | 21.89% | 23.00% | 23.65% | 24.97% | 24.50% | 24.83% | 27.21% | 28.13% | 27.39% | 25.36% | 24.63% | 26.51% | 27.18% | 27.92% | 29.33% | 31.89% | 32.20% | 32.14% | 31.73% | 30.00% | 29.64% | 31.37% | 30.12% | 23.26% | 26.19% | 29.17% | 16.67% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 51.95M | 46.11M | 46.53M | 42.04M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 24.78M | 22.99M | 23.40M | 23.73M | 17.33M | 17.25M | 16.43M | 16.80M | 13.97M | 11.33M | 9.12M | 7.61M | 6.49M | 5.60M | 4.80M | 4.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | -9.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 42.43M | 46.11M | 46.53M | 42.04M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 24.78M | 22.99M | 23.40M | 23.73M | 17.33M | 17.25M | 16.43M | 16.80M | 13.97M | 11.33M | 9.12M | 7.61M | 6.49M | 5.60M | 4.80M | 4.80M | 4.20M | 4.50M | 3.50M | 1.70M | 400.00K |
| Other Expenses | 0.00 | 859.00K | -4.60M | -13.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.79M | 3.24M | 3.35M | 0.00 | 0.00 | 0.00 | 604.00K | 238.00K | 0.00 | 0.00 | 0.00 | 2.33M | 2.09M | 2.10M | 1.90M | 1.70M | 1.70M | 1.30M | 600.00K | 200.00K | 0.00 |
| Operating Expenses | 42.43M | 46.11M | 41.94M | 28.54M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 28.56M | 26.23M | 26.74M | 23.73M | 17.33M | 17.25M | 17.03M | 17.04M | 13.97M | 11.33M | 9.12M | 9.94M | 8.58M | 7.70M | 6.70M | 6.50M | 5.90M | 5.80M | 4.10M | 1.90M | 400.00K |
| Cost & Expenses | 535.25M | 487.23M | 419.78M | 357.06M | 414.54M | 393.60M | 359.32M | 307.01M | 284.01M | 259.31M | 225.29M | 214.29M | 201.08M | 178.04M | 172.98M | 163.81M | 131.65M | 116.60M | 113.24M | 102.32M | 88.57M | 75.87M | 64.00M | 52.84M | 42.67M | 38.50M | 34.00M | 28.60M | 23.30M | 19.00M | 10.30M | 3.60M | 900.00K |
| Interest Income | 3.77M | 859.00K | 199.00K | 142.00K | 46.00K | 93.00K | 88.00K | 93.00K | 81.00K | 18.00K | 7.00K | 6.00K | 5.45M | 586.00K | 8.00K | 260.00K | 273.00K | 332.00K | 361.00K | 146.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.30M | 5.78M | 942.00K | 1.63M | 2.08M | 2.04M | 21.06M | 11.48M | 1.03M | 1.09M | 538.00K | 557.00K | 496.00K | 236.00K | 352.00K | 542.00K | 301.00K | 0.00 | 361.00K | 0.00 | 189.00K | 214.00K | 266.00K | 780.00K | 727.00K | 700.00K | 0.00 | 700.00K | 700.00K | 600.00K | 200.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 15.70M | 14.74M | 11.59M | 10.53M | 10.10M | 9.76M | 9.71M | 8.78M | 7.95M | 6.74M | 5.56M | 5.29M | 5.45M | 5.67M | 5.90M | 5.97M | 4.99M | 4.49M | 4.31M | 4.32M | 3.59M | 2.96M | 2.57M | 2.33M | 2.09M | 2.10M | 1.90M | 1.70M | 1.70M | 1.30M | 600.00K | 200.00K | 0.00 |
| EBITDA | 74.37M | 76.09M | 85.73M | 77.68M | 83.08M | 72.01M | 64.53M | 58.41M | 55.33M | 52.53M | 44.34M | 43.10M | 46.83M | 39.44M | 34.16M | 30.10M | 25.02M | 23.09M | 24.84M | 20.83M | 20.59M | 21.83M | 19.51M | 12.72M | 9.36M | 7.60M | 6.70M | 5.30M | 3.30M | -500.00K | -1.30M | -1.00M | -300.00K |
| EBITDA Ratio | 12.30% | 14.95% | 17.85% | 18.11% | 17.24% | 15.46% | 15.58% | 16.38% | 16.70% | 17.22% | 16.79% | 17.10% | 19.76% | 18.67% | 17.05% | 15.90% | 16.50% | 17.08% | 18.01% | 17.37% | 19.50% | 23.04% | 24.11% | 20.11% | 18.74% | 17.73% | 17.27% | 16.46% | 12.05% | -2.91% | -15.48% | -41.67% | -50.00% |
| Operating Income | 69.56M | 56.80M | 76.77M | 52.41M | 67.43M | 60.31M | 54.73M | 49.53M | 47.29M | 45.77M | 38.77M | 37.80M | 35.93M | 33.19M | 28.43M | 23.88M | 20.04M | 18.60M | 18.88M | 15.99M | 17.00M | 18.87M | 16.95M | 10.38M | 7.27M | 5.50M | 4.80M | 3.60M | 1.60M | -1.80M | -1.90M | -1.20M | -300.00K |
| Operating Income Ratio | 11.50% | 10.27% | 15.51% | 12.39% | 13.99% | 13.29% | 13.22% | 13.89% | 14.28% | 15.00% | 14.68% | 15.00% | 15.16% | 15.71% | 14.11% | 12.72% | 13.21% | 13.76% | 14.29% | 13.52% | 16.10% | 19.92% | 20.94% | 16.42% | 14.55% | 12.50% | 12.37% | 11.18% | 6.43% | -10.47% | -22.62% | -50.00% | -50.00% |
| Total Other Income/Expenses | -20.18M | -1.23M | 2.55M | 13.10M | 3.48M | -103.00K | -20.97M | -11.39M | -7.16M | -1.07M | -531.00K | 52.00K | 446.00K | 350.00K | -344.00K | -282.00K | -5.76M | -5.35M | -5.61M | -366.00K | -5.16M | -5.06M | -5.45M | -4.25M | -3.30M | -2.80M | -2.30M | -1.90M | 300.00K | 0.00 | 0.00 | 0.00 | 300.00K |
| Income Before Tax | 49.38M | 55.57M | 73.20M | 65.51M | 70.91M | 60.21M | 33.76M | 38.15M | 46.34M | 44.70M | 38.24M | 37.25M | 40.88M | 33.54M | 28.08M | 16.51M | 14.28M | 13.25M | 14.30M | 10.78M | 11.78M | 13.72M | 11.50M | 6.14M | 3.96M | 2.70M | 2.50M | 1.70M | 1.90M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 8.16% | 10.05% | 14.79% | 15.49% | 14.71% | 13.26% | 8.15% | 10.70% | 13.99% | 14.65% | 14.48% | 14.78% | 17.25% | 15.88% | 13.94% | 8.80% | 9.41% | 9.80% | 10.82% | 9.11% | 11.16% | 14.49% | 14.21% | 9.71% | 7.93% | 6.14% | 6.44% | 5.28% | 7.63% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 12.16M | 12.16M | 15.27M | 13.02M | 13.65M | 11.37M | 6.03M | 11.88M | 14.65M | 14.27M | 12.24M | 11.03M | 11.10M | 8.84M | 8.11M | 6.51M | 5.47M | 5.06M | 5.51M | 4.10M | 4.45M | 5.24M | 4.43M | 2.40M | 1.57M | 1.10M | 100.00K | 100.00K | 900.00K | 1.00M | 300.00K | 0.00 | 200.00K |
| Net Income | 14.67M | 43.41M | 57.92M | 52.49M | 57.26M | 10.10M | 22.26M | 20.55M | 22.28M | 19.77M | 12.72M | 17.93M | 20.97M | 15.65M | 11.77M | 10.00M | 8.89M | 6.30M | 8.79M | 6.68M | 7.33M | 8.49M | 7.07M | 3.74M | 2.39M | 1.60M | 2.40M | 1.60M | 700.00K | -2.80M | -2.20M | -1.20M | -200.00K |
| Net Income Ratio | 2.43% | 7.85% | 11.70% | 12.41% | 11.88% | 2.23% | 5.38% | 5.76% | 6.72% | 6.48% | 4.82% | 7.11% | 8.85% | 7.41% | 5.84% | 5.33% | 5.86% | 4.66% | 6.65% | 5.64% | 6.94% | 8.96% | 8.74% | 5.91% | 4.79% | 3.64% | 6.19% | 4.97% | 2.81% | -16.28% | -26.19% | -50.00% | -33.33% |
| EPS | 1.28 | 3.34 | 4.49 | 4.09 | 4.49 | 0.80 | 1.76 | 1.64 | 1.77 | 1.62 | 1.05 | 1.52 | 1.78 | 1.34 | 1.01 | 0.84 | 0.75 | 0.54 | 0.74 | 0.56 | 0.66 | 0.77 | 0.70 | 0.13 | 0.12 | 0.05 | 0.08 | 0.05 | 0.02 | -0.27 | -0.22 | -0.12 | -0.02 |
| EPS Diluted | 1.28 | 3.34 | 4.49 | 4.09 | 4.49 | 0.80 | 1.76 | 1.64 | 1.77 | 1.62 | 1.05 | 1.51 | 1.75 | 1.32 | 1.00 | 0.83 | 0.75 | 0.54 | 0.73 | 0.54 | 0.61 | 0.67 | 0.55 | 0.11 | 0.11 | 0.05 | 0.07 | 0.05 | 0.02 | -0.27 | -0.22 | -0.12 | -0.02 |
| Weighted Avg Shares Out | 14.19M | 12.99M | 12.90M | 12.84M | 12.76M | 12.67M | 12.57M | 12.50M | 12.39M | 12.22M | 12.06M | 11.80M | 11.81M | 11.64M | 11.70M | 11.91M | 11.64M | 11.69M | 11.92M | 11.93M | 11.11M | 11.02M | 10.10M | 9.56M | 9.85M | 10.83M | 10.84M | 10.55M | 10.55M | 10.53M | 10.01M | 10.01M | 8.18M |
| Weighted Avg Shares Out (Dil) | 14.19M | 12.99M | 12.90M | 12.84M | 12.76M | 12.67M | 12.57M | 12.50M | 12.39M | 12.22M | 12.08M | 11.90M | 11.98M | 11.87M | 11.81M | 12.06M | 11.72M | 11.69M | 12.04M | 12.37M | 12.02M | 12.67M | 12.86M | 10.70M | 9.85M | 10.83M | 10.84M | 10.55M | 10.55M | 10.53M | 10.01M | 10.01M | 8.18M |
AMED vs. USPH: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Amedisys (AMED) or U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?
AMED or USPH: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks?
AMED vs. USPH: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Amedisys (AMED) or U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued...
AMED vs. USPH: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?
Don't Overlook These Highly Ranked Medical Stocks as Markets Rise
With earnings estimate revisions on the rise for these top medical stocks, they certainly shouldn't be overlooked given their blazing historical performances.
U.S. Physical Therapy to Present at the 14th Annual East Coast IDEAS Conference 2024
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chief Executive Officer, will present at the 14th Annual East Coast IDEAS Conference...
U.S. Physical Therapy to Present at the Jefferies Global Healthcare Conference 2024
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Carey Hendrickson, Chief Financial Officer, will present at the Jefferies Global Healthcare Conference on Wednesday,...
U.S. Physical Therapy to Present at the Bank of America Securities Healthcare Conference 2024
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chief Executive Officer, and Carey Hendrickson, Chief Financial Officer, will present at the...
U.S. Physical Therapy, Inc. (USPH) Q1 2024 Earnings Call Transcript
U.S. Physical Therapy, Inc. (NYSE:USPH ) Q1 2024 Earnings Conference Call May 8, 2024 10:30 AM ET Company Participants Christopher Reading - CEO Jake Martinez - SVP, Accounting and Finance Carey Hendrickson - CFO Eric Williams - COO Conference Call...
U.S. Physical Therapy (USPH) Misses Q1 Earnings Estimates
U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.51 per share, missing the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.59 per share a year ago.
Source: https://incomestatements.info
Category: Stock Reports